Evidence map›Paper›PMID 39206039›Full record

ArticleFrontiers in plant science2024

Overexpression of the ribosome-inactivating protein

Simin Chen, Noémie De Zutter, Anikó Meijer, Koen Gistelinck, Pieter Wytynck, Isabel Verbeke, Vinicius J S Osterne, Subramanyam Kondeti, Tim De Meyer, Kris Audenaert and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in plant science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simin ChenDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Noémie De ZutterLaboratory of Applied Mycology and Phenomics, Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Anikó MeijerDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Koen GistelinckDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Pieter WytynckDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Isabel VerbekeDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Vinicius J S OsterneDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Subramanyam KondetiDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Tim De MeyerDepartment of Data Analysis & Mathematical Modelling, Ghent University, Ghent, Belgium.
Kris AudenaertLaboratory of Applied Mycology and Phenomics, Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Els J M Van DammeDepartment of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome-inactivating proteins (RIPs) are plant enzymes that target the rRNA. The cytoplasmic RIP, called OsRIP1, plays a crucial role in regulating jasmonate, a key plant hormone. Understanding the role of OsRIP1 can provide insights into enhancing stress tolerance and optimizing growth of rice. Transcription profiling by mRNA sequencing was employed to measure the changes in gene expression in rice plants in response to MeJA treatment. Compared to wild type (WT) plants,

Indexed as

jasmonate signalingOryza sativaOsRIP1photosynthesisribosome-inactivating protein

Identifiers

PMID39206039
PMCPMC11349648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.